| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5fe8de81aceb7dd1fac1066925f71f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5af8db21511629b6de87d30d08f093fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1135a1ddd796408403895bb7e01794d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_931d4d00906555f514e7a6a64f00a2b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e1819175e140e66077cf0f72c6c214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e36a14f9c52847368d59c9a48413795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13c2c58d5e619a958d13d608b35c48b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbd1a0126022f0832c14b460e9134444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8c79b8b85b4d20654500a29a1f80135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51fd2dbbae27a75a0dc616e5c5fd4bf3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4857c9735cf746135b6f3546770eb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71dc23384d4e25b1bc3de44e3b0247fe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-752
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_662272121f32bfff92ec0490d5fabd61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a16f51ca80fcccece1fb2b01ac33c907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_734b71c30d9fc240df9737f856f4bc6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ded5aa24503b1fc9bcb2f794c3aa5f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396444272e9b9ba414cad2441b46e63f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f846a7325e62cceff9162f4147587a0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dab034df1ba5e1865e59a8d8d5395c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5882d909f46833dc0b9c4ff58f38554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2ebd7bcd84bebd82c7df8b44e84ac2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99d26c0bc9a005eacf3d8cb37c96f2a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77a9ea48b8e14971a54960acdc2e3e68 |
| publicationDate |
2012-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012196927-A1 |
| titleOfInvention |
Prophylactic and/or therapeutic agent for metabolic syndrome |
| abstract |
A method for screening a substance for treating visceral adiposity syndrome comprises: (1) extracting a total RNA fraction from skeletal muscle collected from non-human mammals of a group to which a predetermined amount of the test substance has been administered and from non-human mammals of a group to which the test substance has not been administered; (2) quantifying the expression quantity of mRNA in the total RNA fraction extracted that encodes a glucose transporter gene by a specific method; and (3) comparing and analyzing the quantity of the test substance ingested, the body weight gain, and the expression quantity of RNA encoding the glucose transporter gene during the administration period for the non-human mammals of the test substance-administered group to these quantities for the non-human mammals that constitute the test substance-unadministered group to thereby determine the effect of the test substance on the metabolic syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548938-B2 |
| priorityDate |
2009-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |